Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model
Copyright © 2024 Elsevier Inc. All rights reserved..
Neosetophomone B (NSP-B) is a unique meroterpenoid fungal secondary metabolite that has previously demonstrated promising anti-cancer properties against various cancer cell lines in vitro. However, its in vivo anti-cancer potential remaines unexplored. To fill this gap in our knowledge, we tested NSP-B's in vivo anti-cancer activity using a zebrafish model, an organism that has gained significant traction in biomedical research due to its genetic similarities with humans and its transparent nature, allowing real-time tumor growth observation. For our experiments, we employed the K562-injected zebrafish xenograft model. Upon treating these zebrafish with NSP-B, we observed a marked reduction in the size and number of tumor xenografts. Delving deeper, our analyses indicated that NSP-B curtailed tumor growth and proliferation of leukemic grafted xenograft within the zebrafish. These results show that NSP-B possesses potent in vivo anti-cancer properties, making it a potential novel therapeutic agent for addressing hematological malignancies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:435 |
---|---|
Enthalten in: |
Experimental cell research - 435(2024), 1 vom: 01. Jan., Seite 113907 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kuttikrishnan, Shilpa [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cell proliferation |
---|
Anmerkungen: |
Date Completed 29.01.2024 Date Revised 29.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.yexcr.2023.113907 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366748335 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366748335 | ||
003 | DE-627 | ||
005 | 20240129232051.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.yexcr.2023.113907 |2 doi | |
028 | 5 | 2 | |a pubmed24n1274.xml |
035 | |a (DE-627)NLM366748335 | ||
035 | |a (NLM)38184222 | ||
035 | |a (PII)S0014-4827(23)00458-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kuttikrishnan, Shilpa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.01.2024 | ||
500 | |a Date Revised 29.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
520 | |a Neosetophomone B (NSP-B) is a unique meroterpenoid fungal secondary metabolite that has previously demonstrated promising anti-cancer properties against various cancer cell lines in vitro. However, its in vivo anti-cancer potential remaines unexplored. To fill this gap in our knowledge, we tested NSP-B's in vivo anti-cancer activity using a zebrafish model, an organism that has gained significant traction in biomedical research due to its genetic similarities with humans and its transparent nature, allowing real-time tumor growth observation. For our experiments, we employed the K562-injected zebrafish xenograft model. Upon treating these zebrafish with NSP-B, we observed a marked reduction in the size and number of tumor xenografts. Delving deeper, our analyses indicated that NSP-B curtailed tumor growth and proliferation of leukemic grafted xenograft within the zebrafish. These results show that NSP-B possesses potent in vivo anti-cancer properties, making it a potential novel therapeutic agent for addressing hematological malignancies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cell proliferation | |
650 | 4 | |a Fungal secondary metabolites | |
650 | 4 | |a Leukemia | |
650 | 4 | |a Neosetophomone B | |
650 | 4 | |a Xenograft model | |
650 | 4 | |a Zebrafish | |
700 | 1 | |a Hasan, Maram |e verfasserin |4 aut | |
700 | 1 | |a Prabhu, Kirti S |e verfasserin |4 aut | |
700 | 1 | |a El-Elimat, Tamam |e verfasserin |4 aut | |
700 | 1 | |a Oberlies, Nicholas H |e verfasserin |4 aut | |
700 | 1 | |a Pearce, Cedric J |e verfasserin |4 aut | |
700 | 1 | |a Alali, Feras Q |e verfasserin |4 aut | |
700 | 1 | |a Ahmad, Aamir |e verfasserin |4 aut | |
700 | 1 | |a Pourkarimi, Ehsan |e verfasserin |4 aut | |
700 | 1 | |a Bhat, Ajaz A |e verfasserin |4 aut | |
700 | 1 | |a Yalcin, Huseyin C |e verfasserin |4 aut | |
700 | 1 | |a Uddin, Shahab |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Experimental cell research |d 1953 |g 435(2024), 1 vom: 01. Jan., Seite 113907 |w (DE-627)NLM000003123 |x 1090-2422 |7 nnns |
773 | 1 | 8 | |g volume:435 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:113907 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.yexcr.2023.113907 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 435 |j 2024 |e 1 |b 01 |c 01 |h 113907 |